Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE

Lisbon 1099-023

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Cancer

Studies at this site

• Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) — Completed